Effect of the Novel Selective Progesterone Receptor Modulator Vilaprisan on Ovarian Activity in Healthy Women

This randomized, double‐blind, parallel‐group study in healthy young women investigated the effect of treatment with vilaprisan (0.5, 1, 2, or 4 mg/day for 12 weeks) on ovarian function by assessing the Hoogland score, which is based on the size of follicle‐like structures as determined by transvagi...

Descripción completa

Detalles Bibliográficos
Autores principales: Schütt, Barbara, Schultze‐Mosgau, Marcus‐Hillert, Draeger, Corinna, Chang, Xinying, Löwen, Stephanie, Kaiser, Andreas, Rohde, Beate
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Women's Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813164/
https://www.ncbi.nlm.nih.gov/pubmed/28940451
http://dx.doi.org/10.1002/jcph.998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813164/
https://www.ncbi.nlm.nih.gov/pubmed/28940451
http://dx.doi.org/10.1002/jcph.998

Ejemplares similares